Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C068073 |
Am 580 |
Am 580 results in increased expression of PRAM1 mRNA | increases expression | 16982809
|
C006632 |
arsenic trioxide |
arsenic trioxide inhibits the reaction [PRAM1 protein results in decreased expression of MIR210 mRNA] | decreases expression|decreases reaction | 18941112
|
C006632 |
arsenic trioxide |
arsenic trioxide inhibits the reaction [PRAM1 protein results in decreased expression of MIR23A mRNA] | decreases expression|decreases reaction | 18941112
|
C006632 |
arsenic trioxide |
arsenic trioxide inhibits the reaction [PRAM1 protein results in decreased expression of RARB mRNA] | decreases expression|decreases reaction | 18941112
|
C027185 |
indirubin |
[tetraarsenic tetrasulfide co-treated with indirubin co-treated with tanshinone] results in increased ubiquitination of and results in increased degradation of PRAM1 protein | affects cotreatment|increases degradation|increases ubiquitination | 18344322
|
C089730 |
rosiglitazone |
rosiglitazone results in increased expression of PRAM1 mRNA | increases expression | 16982809
|
C021751 |
tanshinone |
[tetraarsenic tetrasulfide co-treated with indirubin co-treated with tanshinone] results in increased ubiquitination of and results in increased degradation of PRAM1 protein | affects cotreatment|increases degradation|increases ubiquitination | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
[tetraarsenic tetrasulfide co-treated with indirubin co-treated with tanshinone] results in increased ubiquitination of and results in increased degradation of PRAM1 protein | affects cotreatment|increases degradation|increases ubiquitination | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
tetraarsenic tetrasulfide results in increased ubiquitination of and results in increased degradation of PRAM1 protein | increases degradation|increases ubiquitination | 18344322
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [PRAM1 protein results in decreased expression of MIR23A mRNA] | decreases expression|decreases reaction | 18941112
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of PRAM1 mRNA | increases expression | 17218384
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.34 | 11798837 19825857 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.84 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.90 | 19621015 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.23 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.41 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.73 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
10.13 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
10.13 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
tanshinone |
2.66 | 15849732 19885617 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.66 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.99 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.63 | 11589617 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.60 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.18 | 15553829 14691202 15073043 16217749 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.18 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.32 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.38 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.35 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Am 580 |
8.37 | 17460283 |
MESH:D002386 |
Cataract |
|
Tretinoin |
8.37 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.99 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.60 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.76 | 9407595 |
MESH:D003092 |
Colitis |
|
Am 580 |
11.15 | 17035595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
11.15 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.51 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.74 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.74 | 14991402 10589399 9224671 17551590 9142499 16925845 9211117 9664655 9125849 8800419 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.40 | 15213294 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.55 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
2.99 | 12642470 |
MESH:D004487 |
Edema |
|
rosiglitazone |
3.92 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.91 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.28 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.36 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.78 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
9.10 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
9.10 | 19196556 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.87 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.59 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.17 | 17312396 |
MESH:D005910 |
Glioma |
|
tanshinone |
4.12 | 16955220 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.36 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.60 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.02 | 14991402 9664655 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
8.82 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.82 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.93 | 16778211 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
indirubin |
6.38 | 11275354 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
tanshinone |
5.50 | 19662366 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
3.25 | 12083418 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
3.97 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.12 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.18 | 15992940 17551590 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.75 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.75 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.08 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.70 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
9.65 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
tetraarsenic tetrasulfide |
9.65 | 19208803 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
10.43 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
10.43 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.02 | 17050201 16467208 20471514 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.02 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
8.20 | 16112521 17217047 19642359 15622746 12712474 17869043 15748426 16966277 19035177 17649720 16330433 12679006 16331271 11161223 17107899 19225113 9834237 16823087 15213294 12018890 19075265 15336539 11468182 17712046 16891316 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.20 | 16331271 16140955 16766008 19035177 19225113 17217047 15748426 16823087 17649720 17294898 16935935 16891316 12679006 17107899 17506722 17339181 16788101 17712046 17368321 17361223 17301526 19075265 19029980 19642359 9834237 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.68 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.50 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
2.84 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.84 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
2.42 | 14682389 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
2.89 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.56 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
1.87 | 19825857 11798837 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
3.55 | 16827153 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.87 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.78 | 16940565 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.61 | 17261469 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.29 | 19549372 19417148 14977855 11468182 15949261 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.12 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.87 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.87 | 17596541 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.29 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.52 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.11 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.87 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.87 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
5.11 | 19769630 12452020 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.11 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.13 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.57 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.57 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.47 | 19927285 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.23 | 19131511 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.91 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.19 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.40 | 16116481 16283617 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.29 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.72 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.51 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.51 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.92 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.92 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.05 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.36 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.38 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.57 | 20435036 12973940 11780464 12845720 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.94 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.05 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.39 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.22 | 16287080 |